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ABSTRACT – Background: We examined whether motor speed assessed by the finger
tapping test predicts generalized and specific stable deficits because of a common patho-
genic process in bipolar and schizophrenic patients. 
Methods: One hundred and two patients underwent a battery of neuropsychological
tests. Patients with a score of less than one standard deviation from their siblings’ sample
in two assessments with an interval of one year were defined as suffering from stable
deficits because of a common pathogenic process. In addition to univariate analyses, fac-
tor analyses, ordinal logistic regression, and multiple linear regressions were used. A gen-
eral score was also calculated. 
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Results: No differences were found between schizophrenic and bipolar patients in the
deficits of verbal fluency, shift reasoning ability and executive attention. Schizophrenic
patients had greater persistent cognitive deficit because of a common pathogenic factor in
the verbal memory dimension than bipolar patients. Motor speed predicted the specific
deficits of verbal fluency, shift reasoning, executive attention and the general deficit of
both bipolar I and schizophrenic patients. Bipolar patients suffered a lesser specific deficit
in the verbal memory dimension than schizophrenic patients did, this domain not being
predicted by motor speed. Motor speed predicted the generalized deficit and the specific
dimensions in which schizophrenic and bipolar patients showed no differences. 
Conclusions: These results suggest the presence of general and specific stable cognitive
deficits because of a common pathogenic factor related to psychomotor slowness. Motor
speed seems to be suitable endophenocognitype for schizophrenia and bipolar disorder.
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Introduction
Recent studies on cognitive functioning
confirm consistently that schizophrenic and
bipolar patients suffer from cognitive
deficits1-7. It has been shown that schizo-
phrenia is characterized by a broadly based
cognitive impairment, present since the
onset of the disease regardless of schizo-
phrenic patients’ baseline characteristics
and clinical state8-10. However, a subgroup
of schizophrenic patients with preserved in-
tellectual functions and normal cognitive
performances although with subtle execu-
tive and attentional deficits has also been
identified11,12. Similar cognitive deficits
have also been shown in bipolar patients, al-
though to a lesser degree2,4,13, but at present,
there is no agreement whether these two
groups of patients with generalized or spe-
cific cognitive deficits can be identified in
bipolar disorders. Cognitive deficits in
schizophrenia are relatively stable in pa-
tients even when in remission, e.g., state in-
dependent14,15, whereas in bipolar patients,
although a stable deficit has been shown2,4,
test performances are more sensitive to
symptomatology and clinical state of remis-
sion after an acute episode16,17. Further-
more, some studies carried out on healthy
relatives of schizophrenic and bipolar pa-
tients have also described impairment in
cognitive performances, although to a lesser
degree than the patients, when compared
with normal control subjects18-21. It has
been suggested that schizophrenic patients
suffer neurodevelopmental impairment in
contrast to bipolar patients and that both
groups of patients have similar poor cogni-
tive performances because of a common
pathogenic process that operates once ill-
ness has begun22. Thus, both pathogenic
versus premorbid deficits and generalized
versus specific deficits have been described.
Clinical studies consider psychomotor
poverty as a core symptom of schizophre-
nia23 shown through negative symptoms
(poverty of speech, movement, expressivity
and emotion). In accordance with these
studies, slower cognitive processing speed
and slower motor performances have been
described as a phenotype of the generalized
cognitive deficit in schizophrenic patients
both in cross-sectional24-28 and prospective
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studies29. In contrast to this evidence in
schizophrenic patients, psychomotor pover-
ty is not a core symptom in bipolar disor-
ders. Whether psychomotor speed could be
a phenotype marker of specific or general-
ized cognitive deficits in bipolar patients
has not been clarified. Similarly, whether
psychomotor speed could be a marker in
pathogenic deficits in patients with schizo-
phrenia or bipolar disorder has not been re-
ported either.
Although a number of cognitive deficits
have been reported, methodological issues
must be considered in order to support a
conclusion of pathogenic versus premorbid
deficit. Deficits are usually established by
comparing patients’ cognitive performances
with those of normal controls, and in the
case of family studies, the comparison is
often established with first-degree nonsib-
ling relatives. Potential confounding factors,
such as age, cohort effects, and level of edu-
cation, can influence the overall analysis15.
Moreover, as many previous studies have
been carried out on small samples, cluster-
ing of tests into cognitive domains is usual-
ly done on a theoretical basis, varying
among studies the number and type of tests
used for each domain.
Taking into account these concerns, to as-
sess pathogenic deficits the present study
compares cognitive performances of bipolar
and schizophrenic patients with those of a
sample of patients’ healthy siblings and de-
fines the cognitive domains on an empirical
basis by means of a factor analysis per-
formed on the whole sample. The objectives
of this study were 1) to determine whether in
a large sample of schizophrenic and bipolar I
patients, empirically determined deficits be-
cause of a common pathogenic process are
different in each group, and 2) whether
motor speed performances predicts stability
of (general or specific) cognitive deficits. 
Methods
Subjects
One hundred and two outpatients who
consecutively attended any of the three men-
tal health centers in the metropolitan area of
Valencia that participated in patient recruit-
ment over a nine-month period were recruit-
ed if they fulfilled the criteria of the Diag-
nostic and Statistical Manual of Mental
Disorders-Fourth Edition30 for either schizo-
phrenia (n = 53) or bipolar disorder type I 
(n = 49). A written consent form was ob-
tained from all participants following an ex-
planation of study procedures. The ethics
committee of the University Clinic Hospital
of Valencia (Spain) approved the research
protocol. All subjects were aged between 18
and 60 years. Diagnoses were established
with the Spanish version of the Schedules for
Clinical Assessment in Neuropsychiatry31
after a minimum of one year’s evolution of
the illness. The exclusion criteria used were:
current drug dependence or abuse, electro-
convulsive therapy during the previous six
months, and epilepsy, medical illness or a
known organic cause that may account for
either psychosis or cognitive abnormalities.
Patients were interviewed using the Spanish
adaptation of the Family History Research
Diagnostic Criteria Interview (FH-RDC)32,33
and with the psychotic screening question-
naire of Bebbington and Nayani34 to confirm
the absence of any family or personal history
of psychiatric disorders respectively. They
were assessed two times within a mean inter-
val of 12.5 months. Twelve patients (five
schizophrenic and seven with bipolar disor-
der) discontinued collaboration after inclu-
sion in the study. The final sample consisted
of 48 patients with schizophrenia and 42 with
bipolar disorder. As control subjects, 35 pa-
tients’ healthy siblings who lived in the same
home were recruited, and four refused to
participate. 21 (6 male and 15 female) were
siblings of schizophrenic patients and 14 (4
male and 10 female) were siblings of bipolar
patients.
Neuropsychological assessment
The assessment was performed according
to Balanzá-Martínez et al.2 and Tabarés-
Seisdedos et al.35. Briefly, all patients and
control subjects completed a battery of nine
tests measuring cognitive domains with the
following sequence: executive functions-ab-
straction (Wisconsin Card Sorting Test
(WCST) with three separate scores: cate-
gories, perseverative errors, and nonpersever-
ative errors), categorical and phonological
verbal fluency (Category Instant Generation
Test (CIG); FAS Test of the Controlled Oral
Word Association Test), immediate and
working memory (the forward and backward
parts of the Digit Span Test from the Wech-
sler Adult Intelligence Scale-Revised or
WAIS-R), verbal memory (VM, the Babcock
Story Recall Test-Immediate and Delayed
Free Recall), visual-motor processing atten-
tion (the Stroop Color and Word Test with
the Color-Word Interference trial), sustained
attention from the Asarnow Continuous Per-
formance Test (CPT) (the total number of
hits and the total number of false alarms
were calculated), and motor speed (finger
tapping test FT). The last sequence was con-
sistent for all subjects and was administered
on the same day that the subject’s clinical
state was assessed.
Clinical assessment and
sociodemographic and evolutive
variables
On the same day, patients were rated ac-
cording to the Positive and Negative Syn-
drome Scale36,37, for depressive symptoms
with the Hamilton Rating Scale for Depres-
sion38,39 and for manic symptoms with the
Clinician-Administered Rating Scale for
Mania40,41. Classification of longitudinal
course for schizophrenia was done by means
of DSM-IV specifiers. As sociodemographic
variables, gender and age were used. The
evolutive variables used were years of illness
duration, number of hospitalizations, and
number of episodes of illness. As premorbid
variables, we used age at onset, premorbid
social adjustment, and years of education.
Finally, the equivalent doses of antipsychotic,
benzodiazepine, and anticholinergic medica-
tion, and daily doses of lithium and number
of cigarettes smoked per day were used.
Statistical analysis
Clustering of the cognitive variables
We applied principal components analysis
to test for clustering of the cognitive vari-
ables. The adoption of a four-factor structure
was based on the rule of eigenvalues greater
than 1 for each interpretable factor. Four cog-
nitive domains were then extracted using a
varimax (orthogonal) rotation: executive at-
tention (Stroop test, Digit Span Forward,
Digit Span Backward, and Asarnow CPT),
shift reasoning (categories, perseverative er-
rors, and nonperseverative errors of the
WCST), verbal memory (Immediate and De-
layed Recall of the Babcock Memory Test),
and verbal fluency (FAS and CIG). Each test
score was Z-transformed based on the sib-
ling control group’s mean and standard devi-
ation. Persistent deficit was defined as hav-
ing a score below 1SD of the control group
mean in both cognitive assessments. Then a
test-deficit binary variable (deficit vs no
deficit) was obtained for each neuropsycho-
logical test. A domain deficit score for each
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cognitive domain was obtained by comput-
ing the proportion of test-deficit variables
that each domain had (range 0-1); thus, a pa-
tient scoring 0.5 in one domain would have
been classified as deficit in half of the neu-
ropsychological tests of that domain, 0.25
would not have been classified as deficit in a
quarter of the neuropsychological tests of
that domain, a score of 1 would not have
been classified as deficit in any of the neu-
ropsychological tests of that domain etc. A
global deficit score was obtained by adding
the scores of each domain.
Analytical strategy
First, we studied the association between
the clinical, evolutive, and premorbid vari-
ables with the binary deficit variables of
each neuropsychological test, the specific
domain deficits, and the general deficit vari-
ables. The χ2 test, t test, Mann-Whitney U
test, and Pearson and Spearman correlation
tests were used for this univariate analysis.
Second, those variables yielding significant
results were analyzed by ordinal logistic re-
gression for the deficit dimension variables,
and multiple regression analysis was used
for the global deficit variable as this vari-
able had a normal distribution. In order to
control multiple comparison variable bias,
we repeated the analyses using Bonferroni’s
correction employing only those variables
that reached a significance level < 0.02 in
the univariate analyses. In both cases, the
results were similar.
Results
Patients and siblings did not show statisti-
cal differences for age (mean for patients = 38
years, mean for siblings = 34, t = 1.6, p = ns)
or years of education (mean for patients =
9.8, mean for siblings = 11, t = -1.4, p = ns).
Women accounted for a higher proportion in
the control group (74%) than in the patient
group (39%) (χ2 = 12.8, p < 0.001). Clinical,
evolutive and sociodemographic characteris-
tics of the patients are reported in Table I.
With respect to the neuropsychological
variables, schizophrenic patients had a
greater risk of deficit than bipolar patients
did in the immediate (OR = 1.6, IC 95% =
1.1-2.4) and delayed (OR = 1.6, IC 95% =
1.1-2.4) free recall of the Babcock verbal
memory test. No risk of deficit in any other
neuropsychological test was significant
(Table II).
Considering the cognitive dimensions,
schizophrenic patients scored higher in ver-
bal memory deficit than bipolar patients did
(Mann-Whitney U = 946, p < 0.01), and no
differences were found in executive atten-
tion, shift reasoning, or verbal fluency
deficits. Correlations between cognitive di-
mensions and evolutive and clinical vari-
ables are shown in Table III. Neither dimen-
sion deficit nor the general deficit showed
differences in the history of psychoses. The
doses of antipsychotic medication correlat-
ed with the verbal memory deficit (ρ = 0.27,
p < 0.01). The remaining deficit variables
did not correlate with antipsychotic, benzo-
diazepine, or anticholinergic doses.
In schizophrenic patients, the course of
the illness was associated with global deficit
(Kruskal-Wallis = 7.9, p < 0.05). Specifical-
ly, those who had an evolutive type without
interepisodic residual symptoms had lower
global deficit than those who had in-
terepisodic residual symptoms (Mann-
Whitney U = 72.5, p < 0.05) or continuous
symptoms (U = 34.5, p < 0.05). Functional
outcome (GAF) was related with executive
attention (ρ = 0.27, p < 0.01), verbal memo-
ry (ρ = 0.38, p < 0.001), verbal fluency 
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(ρ = -0.25, p < 0.01) and general (ρ = 0.28,
p < 0.01) deficits. GAF was not correlated
with shift reasoning ability deficit. The
number of cigarettes smoked per day was
associated with a lower deficit in verbal flu-
ency (ρ = 0.23, p < 0.05), shift reasoning
ability (ρ = 0.37, p < 0.001), and verbal
memory (ρ = 0.25, p < 0.01) deficits.
Table I
Descriptive variables of the sample
Schizophrenia Bipolar disorder t p
Mean SD Mean SD
Age 33.9 8.0 42.3 11.3 -4.2 < 0.001
Educational level (years of schooling) 9.8 3.0 9.7 4.0 0.05 ns*
GAF 60.2 12.3 76.9 12.3 -6.8 < 0.001
Age at the first episode 25.4 6.8 29.5 9.7 -2.4 < 0.05
Years of illness 8.5 7.1 12.4 9.6 -2.3 < 0.05
Number of episodes 2.5 1.9 5.4 3.3 -4.7 < 0.001
Number of hospitalizations 0.66 1.2 1.2 1.6 -2.2 < 0.05
Duration of the episode 153.8 318.8 8.5 5.6 3 < .01
Number of days of hospitalization 1.0 1.8 1.9 2.7 -1.8 ns
PANSS P 12.8 5.0 10.3 5.3 2.5 < 0.05
PANSS N 21.5 8.2 10.7 4.0 8.4 < 0.001
PANSS G 32.8 8.3 24.9 8.4 4.7 < 0.001
HRSD 6.3 4.4 4.5 4.5 2.0 < 0.05
CARS-M 2.3 3.9 2.4 4.2 -0.08 ns
Premorbid adaptation 1.9 1.3 1.4 1.5 1.5 ns
Antipsychotic mg 866.2 666.2 187.2 309.4 6.6 < 0.001
Lithium mg 0.0 0.0 489.7 465.5 -7.3 < 0.001
Carbamazepine mg 32.0 141.1 279.1 475.7 -3.5 < 0.001
Diazepam mg 4.4 10.8 12.2 17.6 -2.6 < 0.001
Biperiden mg 1.1 4.2 0.1 0.6 1.7 ns
*not significant.
Table II
Cognitive deficit according to diagnosis and neuropsychological test
Test Bipolar Schizophrenia Total χ2 p
Without With Without With Without With 
deficit deficit deficit deficit deficit deficit
n n n n n n
Stroop 32 10 34 14 66 24 0.3 ns*
Verbal fluency categories 33 9 32 16 65 25 1.5 ns
Verbal fluency semblances 35 7 36 12 71 19 0.9 ns
WCST categories 34 8 38 10 72 18 0.5 ns
WCST errors 25 17 35 13 60 30 1.8 ns
WCST perseverances 34 8 42 6 76 14 0.7 ns
Digit span backward 32 10 36 12 68 22 0.02 ns
Digit span forward 39 3 43 5 82 8 0.3 ns
Delayed verbal memory 31 11 23 25 54 36 6.2 0.02
Immediate verbal memory 34 8 26 22 60 30 7.2 0.008
CPT Alarms 38 4 47 1 85 5 2.3 ns
CPT Hits 38 4 38 10 76 14 2 ns
*not significant.
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Motor speed
Males had a higher motor speed (FT)
than women did (men mean = -0.9, women
mean = -1.5, t = 3.5, p < 0.001), and siblings
had a higher motor speed than patients did
(-1.2 for patients vs 0.6 for siblings, t = 3.1,
p < 0.01). Motor performances were corre-
lated with doses of benzodiazepines (r = -
0.28, p < 0.01) and the number of cigarettes
smoked per day (r = 0.24, p = 0.05). FT cor-
related with Stroop (r = -0.46, p < 0.001),
WCST categories (r = 0.41, p < 0.001),
WCST errors (r = 0.43, p < 0.001), WCST
perseverative errors (r = -0.35, p < 0.001),
premorbid educational level (r = 0.34, p <
0.001), Asarnow CPT total (number of) hits
(r = 0.5, p < 0.001), Babcok Story Recall
immediate verbal memory (r = 0.27, p <
0.01), and Babcok Story Recall delayed ver-
bal memory (ρ = 0.25, p < 0.05). CPT
alarms did not correlate with FT. No differ-
ences were found by diagnostic group
(bipolar vs schizophrenic) or type of an-
tipsychotic (typical vs atypical).
FT correlated with every deficit dimen-
sion: executive attention (ρ = 0.44, p <
0.001), shift reasoning (ρ = 0.38, p < 0.001),
verbal memory (ρ = 0.26, p < 0.001), verbal
fluency (ρ = 0.38, p < 0.001), and general
deficit (ρ = 0.45, p < 0.001) (Table III).
Multivariate analysis
Ordinal Logistic Regression showed that
only FT (coeff. = 0.85, Wald χ2 = 6.5, p <
0.01) predicted executive attention deficit.
Educational level, age, PANSS-P, PANSS-N
and PANSS-G did not reach a significant
level (Model χ2 = 32.8, p < 0.001, Nagelk-
erke R2 = 0.33). shift reasoning deficit was
Table III
Spearman correlation coefficients between cognitive deficits and clinical and evolutive variables
Executive Shift reasoning Verbal memory Verbal fluency General 
deficit deficit deficit deficit deficit
Finger tapping 0.438** 0.380** 0.263** 0.385** 0.450**
Age -0.231* -0.321** -0.047 -0.138 -0.232*
Educational level (years of schooling) 0.318** 0.334** 0.260** 0.221* 0.374**
Premorbid adaptation -0.139 -0.027 -0.246* -0.090 -0.150
Age at first episode -0.097 -0.109 0.014 -0.126 -0.061
Years of illness -0.182 -0.209* -0.077 -0.060 -0.207*
Number of episodes -0.106 -0.055 0.080 0.067 -0.036
Number of hospitalizations -0.170 0.001 0.092 0.002 -0.002
Duration of episodes -0.067 -0.073 -0.050 -0.101 -0.067
Duration of hospitalizations -0.148 0.000 0.028 0.000 -0.026
PANSS P -0.226* -0.087 -0.353** -0.164 -0.299**
PANSS N -0.236* -0.085 -0.361** -0.328** -0.315**
PANSS G -0.204* 0.118 -0.388** -0.155 -0.220*
GAF 0.270** -0.029 0.385** 0.248* 0.277**
Mg of antipsychotic -0.160 0.172 -0.260** -0.182 -0.159
Lithium 0.048 -0.028 0.272** 0.175 0.170
Carbamazepine 0.065 -0.066 0.019 -0.046 -0.046
Diazepam -0.174 0.013 -0.056 0.091 -0.040
Number of cigarettes smoked per day 0.185 0.374** 0.251* 0.230* 0.291**
Biperiden -0.056 -0.028 -0.096 -0.112 -0.056
*p < 0.05 (two-tailed test), **p < 0.01 (two-tailed test).
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predicted by educational level (coeff. = 0.2,
Wald χ2 = 6.1, p < 0.05), number of ciga-
rettes smoked per day (coeff. = 0.05, Wald
χ2 = 6.6, p < 0.05) and FT (coeff. = 0.72,
Wald χ2 = 6.1, p < 0.01). Age and illness du-
ration did not reach a significant level
(Model χ2 = 34.6, p < 0.001, Nagelkerke R2
= 0.36). Verbal memory deficit was predict-
ed by number of cigarettes smoked per day
(coeff. = 0.044, Wald χ2 = 4.7, p < 0.05).
Educational level, premorbid adjustment,
FT, PANSS-P, PANSS-N, PANSS-G, doses
of antipsychotic and diagnosis did not reach
a significant level (Model χ2 = 34.9, p <
0.001, Nagelkerke R2 = 0.38). Verbal fluen-
cy deficit was predicted by FT (coeff. =
0.78, Wald χ2 = 6.0, p < 0.05) and PANSS-
N (coeff. = -0.05, Wald χ2 = 3.7, p < 0.05).
Educational level and number of cigarettes
smoked per day did not reach a significant
level (Model χ2 = 23.9, p < 0.001, Nagelk-
erke R2 = 0.28). Gender did not reach a sig-
nificant level in any of the four models. 
Multiple regression showed that general
deficit was predicted by FT (β = 0.3, p <
0.001), educational level (β = 0.26, p <
0.01), PANSS-N (β = -0.26, p = 0.01) and
number of cigarettes smoked per day (β = 0.2,
p < 0.05, R2 = 0.41, Model f = 10.98,
p = 0.001). Age and PANSS-G were not in-
cluded in the model.A summary of the mul-
tivariate models is shown in Table IV.
Discussion
The current study has shown the exis-
tence of persistent cognitive deficits (specif-
ic and generalized) in a large sample of
bipolar and schizophrenic outpatients. Both
types of patients showed similar deficits, ex-
cept for the verbal memory domain in
which schizophrenic patients suffer from
more severe deficits. Motor speed predicted
persistence of deficits of executive atten-
tion, shift reasoning, verbal fluency and a
general deficit, which are the dimensions
that affect schizophrenic and bipolar pa-
tients to the same degree, in contrast to ver-
bal memory deficit, which was not predict-
ed by motor speed.
Executive attention, shift reasoning, and
verbal fluency deficits are attributable to a
common pathogenic process as their assess-
Table IV
Summary of multivariate models: predictive variables of the deficits
Deficit Variable R2 of the model p
Executive attention Motor speed 0.33a < 0.001
Shift reasoning Motor speed 0.36a < 0.001
Years of schooling
Number of cigarettes per day
Verbal memory Number of cigarettes per day 0.34a < 0.001
Verbal fluency Motor speed 0.28a < 0.001
PANSS-N
General Motor speed 0.41b < 0.001
Years of schooling
Number of cigarettes per day 
PANSS-N
a = Nagelkerke R2 (Ordinal logistic regression).
b = R2 (Multiple regression).
ment has been done in comparison with a
sample of siblings with the same character-
istics of age and educational level, therefore
controlling potential confounding factors
such as socioeconomic level or cohort ef-
fects that are usually related to performance
in neuropsychological tests. The higher pro-
portion of females in the sibling sample is
accounted for by the proportion of male sib-
lings that had daytime work commitments
and were therefore less likely to collaborate
in the study. Nevertheless, multivariate
analyses allowed us to control this con-
founding factor . The dimensions used had a
good ecological validity as they are factors
extracted from the sample studied and are
therefore representative of the consecutive
sample of patients attending three mental
health centers. Our results confirm a com-
mon attention deficit factor shared by schiz-
ophrenic and bipolar patients related to
motor speed. Factor analysis compiled the
attention tests (Stroop, Digit Symbol, and
Trail Making) into one dimension related
with speed processing42-46. The relationship
between speed processing deficits and at-
tention deficits has been shown in schizo-
phrenic patients suggesting common
deficits in temporal perception process-
es8,9,28. The specific mechanism of poor per-
formances in speed tasks and speed process-
ing in patients with schizophrenia is not
clear, although some studies have explained
it by a deficit in the translation of stimulus-
response47 or by instable attention reaction
times that are affected when attention de-
mands are increased26,48.
WCST is orthogonal with other executive
tests and requires a set of tasks, some of
them frontal, which involve mainly numeric
complex visomotor processing and the abil-
ity to identify a relevant stimuli, working
memory, mental set shifting, and speed pro-
cessing46,49,50. In accordance with these re-
sults, our study has classified the WCST as
a whole dimension of shift reasoning related
to speed processing. Speed processing and
executive function impairments seem to
persist over time51.
Factor analysis compiled the immediate
and delayed memory tasks of the Babcock
memory test, which do not take into account
time control, into one single memory di-
mension. In our study, schizophrenic pa-
tients showed greater deficit than bipolar
patients did in these specific tests and in the
memory dimension. Memory disorders have
been shown in schizophrenic and, to a lesser
degree, in bipolar patients13. Our results co-
incide with Daban et al.13, who have shown
that verbal memory, and specifically imme-
diate memory, seems to distinguish between
both diagnostic groups, although these
deficits are not specific to any diagnostic
group. In contrast with our study, the associ-
ation between memory deficit and speed
processing has also been reported52; there-
fore, the verbal memory deficit could have
been predicted by motor speed in our study.
This difference can be accounted for if we
consider that the tests used for memory
measurements in other studies resemble
those of verbal fluency and executive atten-
tion that we have used. Psychomotor func-
tions have been reported to be significantly
reduced in remitted bipolar patients as com-
pared with healthy controls53. Schizo-
phrenic and bipolar patients were neurocog-
nitively impaired, with the schizophrenic
group performing significantly worse on
conceptual ability, verbal leaning, visuospa-
tial processing, and motor speed54. More-
over, Seidman et al.55 also reported that
bipolar patients showed moderate-to-large
effect size decrements on perceptual–motor
speed. Cognitive–motor disturbances may
help to explain impairments in daily func-
tioning in remitted bipolar patients56.
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Factor analysis grouped phonemic fluency
(words) and semantic fluency (animals) into
the verbal fluency dimension. This result is
consistent with Henry and Crawford57, who
consider semantic and phonemic deficits as
shortfalls associated with general intelli-
gence and psychomotor speed. The verbal
fluency tests tap somewhat different abilities
compared with other executive measures
(e.g., WCST) and although the mechanisms
underlying verbal fluency remain to be
worked out, word knowledge, episodic mem-
ory, working memory and speed of process-
ing information appear to be integral compo-
nents. In our study, verbal fluency deficits
attributable to a common pathogenic factor
are predicted by motor speed in both schizo-
phrenic and bipolar disorders, and according
to Henry and Crawford58, this deficit would
show a generalized intellectual deficit in-
stead of specific impairments in executive
control.
Cigarette consumption has been reported
to be higher among psychiatric patients
than in the general population59. This be-
havior has been attributed to either a risk
factor for some illnesses like schizophrenia
or the search for remedies to alleviate and
improve cognitive symptoms60. In our sam-
ple, cigarette consumption predicts a lesser
deficit associated with verbal memory and
shift reasoning. These results coincide with
other studies that have shown an important
role of nicotinic receptors on attention,
learning and memory functions61, and by
improvements in the performances of these
functions after nicotine administration in
schizophrenic patients62,63 or as a result of
cigarette smoking64. A relationship be-
tween tobacco consumption and motor
speed in schizophrenic patients regardless
of other clinical, evolutive or medication
variables has been shown65, confirming its
stimulant effect by improving speed pro-
cessing in medicated schizophrenic pa-
tients. Our results suggest that these effects
could also be experienced by bipolar disor-
der patients with cognitive deficits and that
the effect is not only short term but also
long term.
Our finding that motor speed predicts
cognitive deficits because of a pathogenic
process presumably common to bipolar and
schizophrenic disorders follows recent
studies on the relationship between D2
dopamine receptor density and finger tap-
ping tasks66,67. These authors have shown
that striatal dopamine D2 receptor density is
associated with an impaired performance in
motor processing and time tasks in both
schizophrenic and healthy subjects, with
correlations between striatum D2 receptor
density and finger tapping tasks that range
between 0.5 for healthy subjects and 0.7 for
schizophrenic patients. Furthermore, D2 re-
ceptor density correlated mainly with neu-
ropsychological tests in which time mea-
suring was involved (attentional tests), and
a decrease in striatal dopamine D2 receptor
density seemed to be associated with im-
paired performance in optimal timing tasks
and motor speed processing. According to
these results, the sensitivity of FT to age
and to side effects of antipsychotic medica-
tion could also be explained in part by a de-
cline of D2 receptor density. Although an-
tipsychotic treatment is associated with a
reduction in striatal D2 densities and perfor-
mance on cognitive tasks is also known to
be influenced by neuroleptics, in our study,
neither the type of antipsychotic nor the
doses have been associated with any deficit
dimension.
One strength of this study is the defini-
tion of deficit by comparing a patient’s
cognitive performance with that of a sam-
ple of siblings living in the same home,
avoiding confounding sociodemographic
and rearing factors. The control group had
a higher proportion of women, probably
because of gender roles in Spain associated
with care of relatives and a limitation of
this study is that the small number of sib-
lings not living in the patient’s home,
mainly males, would limit the external va-
lidity of the definition of deficit not being
generalizable to this subgroup of siblings.
Nevertheless, although the extent that the
cognitive performances of these groups of
siblings differ is not known, it is probable
that they would not be influenced by gen-
der roles. Eighty-eight percent of the sam-
ple finished the follow-up, and there were
no significant differences between bipolar
and schizophrenic patients. Potential loss
of validity because of attrition would be
small and would not affect diagnoses. Al-
though the participants in this study were
enrolled from three different psychiatric
outpatient units and their symptom severity
was similar to the subjects included in
some studies’ large samples, the extent to
which we can generalize those findings is
unknown.
Compared with their healthy siblings, a
subgroup of schizophrenic and bipolar pa-
tients showed persistent cognitive deficits.
Bipolar patients suffered a lesser deficit in
the verbal memory dimension than schizo-
phrenic patients did, this domain not being
predicted by motor speed. On the other
hand, motor speed predicted the generalized
deficit and the specific domains in which
schizophrenic and bipolar patients showed
no differences. These results suggest the
presence of general and specific persistent
cognitive deficits because of a common
pathogenic factor of both disorders that is
related to psychomotor slowness. Thus,
motor speed seems to be suitable endophe-
nocognitype for schizophrenia and bipolar
disorder68-71.
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